These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 26909847

  • 1. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.
    Fraser KM, Haight JL, Gardner EL, Flagel SB.
    Behav Brain Res; 2016 May 15; 305():87-99. PubMed ID: 26909847
    [Abstract] [Full Text] [Related]

  • 2. Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign-tracking behavior in rats.
    Fitzpatrick CJ, Creeden JF, Perrine SA, Morrow JD.
    Hippocampus; 2016 Nov 15; 26(11):1424-1434. PubMed ID: 27438780
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 Modulation of Sign and Goal Tracking in Rats.
    Lopez JC, Karlsson RM, O'Donnell P.
    Neuropsychopharmacology; 2015 Aug 15; 40(9):2096-102. PubMed ID: 25759299
    [Abstract] [Full Text] [Related]

  • 4. Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats.
    Flagel SB, Watson SJ, Robinson TE, Akil H.
    Psychopharmacology (Berl); 2007 Apr 15; 191(3):599-607. PubMed ID: 16972103
    [Abstract] [Full Text] [Related]

  • 5. The tendency to sign-track predicts cue-induced reinstatement during nicotine self-administration, and is enhanced by nicotine but not ethanol.
    Versaggi CL, King CP, Meyer PJ.
    Psychopharmacology (Berl); 2016 Aug 15; 233(15-16):2985-97. PubMed ID: 27282365
    [Abstract] [Full Text] [Related]

  • 6. Lesions of the paraventricular nucleus of the thalamus differentially affect sign- and goal-tracking conditioned responses.
    Haight JL, Fraser KM, Akil H, Flagel SB.
    Eur J Neurosci; 2015 Oct 15; 42(7):2478-88. PubMed ID: 26228683
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.
    Bacharach SZ, Nasser HM, Zlebnik NE, Dantrassy HM, Kochli DE, Gyawali U, Cheer JF, Calu DJ.
    Psychopharmacology (Berl); 2018 Oct 15; 235(10):3031-3043. PubMed ID: 30109373
    [Abstract] [Full Text] [Related]

  • 8. The lateral hypothalamus and orexinergic transmission in the paraventricular thalamus promote the attribution of incentive salience to reward-associated cues.
    Haight JL, Campus P, Maria-Rios CE, Johnson AM, Klumpner MS, Kuhn BN, Covelo IR, Morrow JD, Flagel SB.
    Psychopharmacology (Berl); 2020 Dec 15; 237(12):3741-3758. PubMed ID: 32852601
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of corticosterone on the acquisition of Pavlovian conditioned approach behavior in rats is dependent on sex and vendor.
    Turfe A, Westbrook SR, Lopez SA, Chang SE, Flagel SB.
    Horm Behav; 2024 Aug 15; 164():105609. PubMed ID: 39083878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of Dopamine Neurons Prevents Incentive Value Encoding of a Reward Cue: With Revelations from Deep Phenotyping.
    Iglesias AG, Chiu AS, Wong J, Campus P, Li F, Liu ZN, Bhatti JK, Patel SA, Deisseroth K, Akil H, Burgess CR, Flagel SB.
    J Neurosci; 2023 Nov 01; 43(44):7376-7392. PubMed ID: 37709540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential involvement of dopamine receptor subtypes in the acquisition of Pavlovian sign-tracking and goal-tracking responses.
    Roughley S, Killcross S.
    Psychopharmacology (Berl); 2019 Jun 01; 236(6):1853-1862. PubMed ID: 30683942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.